Home Business Gilead to buy cancer drugmaker Immunomedics in $21 billion deal

Gilead to buy cancer drugmaker Immunomedics in $21 billion deal

183
4
Gilead to buy cancer drugmaker Immunomedics in $21 billion deal

Gilead Sciences will acquire biotech company Immunomedics in a $21 billion deal that will expand Gilead’s availability of cancer treatments, the companies announced on Sunday. 
The deal will provide…
Read More

4 COMMENTS

  1. 850362 11447A genuinely exciting examine, I could possibly not concur entirely, but you do make some genuinely legitimate points. 138660

  2. 46416 98844You completed several good points there. I did specific searches on the concern and discovered numerous individuals go in conjunction with along along with your weblog. 471214

  3. 443085 516611Maximize your by how a large amount of gear are employed internationally and will often impart numerous memory employing that your is also fighting that can be a result from our team rrnside the twenty 1st centuries. everyday deal livingsocial discount baltimore washington 351196

LEAVE A REPLY

Please enter your comment!
Please enter your name here